New York bio-cluster advocates win new AIDS lab

Working with a $23 million grant from the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative has completed a deal to create a 36,000-square-foot research lab in the Brooklyn Army Terminal. The terminal is at the center of New York's efforts to create a biotech cluster in the city. Some 114 biotech companies have a presence in the Big Apple, but for most that translates into sales and marketing ops. New York wants to attract more R&D efforts.

- read The New York Times article

Related Article:
New York gov pushing major stem cell program. Report
Gates Foundation restructures, refocuses. Report

Suggested Articles

Merck’s TIGIT-blocking prospect and PD-1 med Keytruda shrank tumors in 29% of lung cancer patients who had never tried a checkpoint inhibitor.

Merck's HIF-2α inhibitor, picked up in its $1 billion Peloton buyout, shrank kidney tumors in 36% of patients and showed promise in other tumors, too.

Amunix reported that a single dose of its lead T-cell engager caused caused large HER2-positive tumors to shrink in mice.